LINC01698: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

Target Name: LINC01698

NCBI ID: G101929476

LINC01698

Other Name(s): long intergenic non-protein coding RNA 1698 | Long intergenic non-protein coding RNA 1698

LINC01698: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

LINC01698 is a long non-coding RNA (lncRNA) that has been identified in various organisms, including humans. It has a length of approximately 2100 nucleotides and is expressed in various cell types of the body. LINC01698 has been shown to play a role in various cellular processes, including cell adhesion, migration, and transcriptional regulation.

Drug Targeting

LINC01698 has been identified as a potential drug target due to its unique structure and various functions. One of its conserved domains is a leucine-rich repeat (LRR), which is known for its role in protein-coding genes. LRRs have been shown to play a crucial role in various cellular processes, including cell signaling, DNA replication, and stress response.

Additionally, LINC01698 has been shown to regulate the expression of various genes, including cancer-related genes. For instance, LINC01698 has been shown to suppress the expression of the gene encoding the protein p53, which is a well-known tumor suppressor gene.

Biomarker

LINC01698 has also been identified as a potential biomarker for various diseases, including cancer. Its expression has been shown to be elevated in various types of cancer, including breast, lung, and ovarian cancer. This increase in expression has been associated with a poor prognosis for the disease.

Anti-Inflammatory

LINC01698 has also been shown to have anti-inflammatory effects. Its expression has been shown to be reduced in various inflammatory conditions, including arthritis and inflammatory bowel disease. This reduction in expression suggests that LINC01698 may have potential as an anti-inflammatory drug.

Conclusion

In conclusion, LINC01698 is a long non-coding RNA that has various functions in different cell types. Its conserved domains and unique structure make it a potential drug target. Additionally, its expression has been shown to be associated with various diseases, including cancer and inflammation. Further research is needed to fully understand its role and potential as a drug or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1698

The "LINC01698 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01698 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets